688202.SS
688202.SS
CNE100003NQ8
SHANGHAI MEDICILON INC
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 (Est.) Change %
Total Revenue 1.163.062.464 0
--
Cost of Revenue 961.177.935 --
--
Gross Profit 201.884.528 --
--
299.630.681 --
--
Operating Income -97.746.152 --
--
Pretax Income -184.996.410 --
--
Net Income Common Stockholders -167.828.221 --
--
-- --
--
-- --
--
ende